Notes / Company Kobo Biotech Ltd. KOBO BSE 531541 ISIN INE881A01015 Pharmaceuticals Fundamentals Market cap₹17.92 cr ROE4.34% Debt / equity-1.09 52-week range 1.99 — 7.38 The timeline — 1 note on Kobo Biotech Ltd. July 2026 16 Jul 26 · 12:33 PM IST Lead Lead · Micro cap Kobo Biotech's resolution plan misses 10 July deadline, no funds yet NCLT-approved ₹70.11 crore plan from Beaufond Industries was due within 60 days. As of 14 July, terms remain unfulfilled. Monitoring committee to decide next steps. Verify on exchange BSE filings for KOBO NSE filings for KOBO